Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$17M Buy
208,226
+1,964
+1% +$128K 0.03% 455
2026
Q1
$9.45M Buy
206,262
+9,454
+5% +$546K 0.02% 543
2025
Q4
$14.6M Buy
196,808
+11,435
+6% +$823K 0.02% 469
2025
Q3
$13.5M Buy
+185,373
New +$14.1M 0.02% 468
2022
Q3
Sell
-30,058
Closed -$543K 997
2022
Q2
$543K Buy
30,058
+5,748
+24% +$156K ﹤0.01% 1014
2022
Q1
$1.13M Buy
+24,310
New +$1.27M 0.01% 960

Other funds holding AFRM

Aviva's AFRM Position: Q2 2026 in Review

Aviva increased its Affirm (AFRM) stake by 0.95% in Q2 2026, buying an estimated $128K and bringing the position to 208,226 shares worth $17M. The position accounts for 0.03% of the portfolio, ranked #455.

Aviva first reported a position in AFRM in Q1 2022 and has held it in 6 quarters since. 660 funds tracked by Wall St. Rank hold AFRM as of Q2 2026.

  • Aviva held 208,226 shares of Affirm worth $17M as of Q2 2026.
  • Aviva bought 1,964 Affirm shares in Q2 2026, an estimated $128K.
  • Affirm made up 0.03% of Aviva's portfolio in Q2 2026, its #455 holding.
  • Aviva first reported a position in Affirm in Q1 2022 and has held it in 6 quarters since.
  • 660 funds tracked by Wall St. Rank held Affirm as of Q2 2026.

Based on Aviva's 13F filing for Q2 2026, filed 13 Aug 2026.